ALUNBRIG 90 mg + 180 mg, film-coated tablet 7 tablets
Active ingredients: Brigatinib
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet7 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALUNBRIG 90 mg + 180 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- Plaquette thermoformée (ACLAR RX) polytrifluorochloroéthylène aluminium de 7 comprimés + plaquettes thermoformées ACLAR RX) polytrifluorochloroéthylène aluminium de 21 comprimés (Kit d’initiation de 28 comprimés)
- Marketing authorisation holder
- TAKEDA PHARMA (DANEMARK)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Mar 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61066196CIP73017195CIP133400930171950Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRIGATINIBcomprimé 180 mg | 180 mg · un comprimé | SA |
| BRIGATINIBcomprimé 90 mg | 90 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.